This decision aid is intended for individuals who are considering psilocybin-assisted therapy in the context of existential distress.
It provides neutral, clear, and evidence-based information. Its purpose is to help patients reflect on their values, better understand the potential benefits, risks, and uncertainties associated with this type of intervention, and make an informed decision in collaboration with their healthcare team.
The tool was developed according to best practices in shared decision-making, in partnership with patient partners and healthcare professionals.
It is freely accessible, although voluntary contributions are appreciated and can be made as donations to our team through this support fund.
This tool was developed by Ariane Bélanger, under the supervision of Professor Michel Dorval, as part of her Master’s degree in Pharmaceutical Sciences at Université Laval.
Writing team:
Ariane Bélanger, B.N., Michel Dorval, Ph.D., Sue-Ling Chang, M.Sc., Florence Moureaux, patient partner, Jean-François Stephan, M.D., and Diane Tapp, Ph.D.
We invite you to share your feedback on this decision aid using this form.